🥇 First rule of investing? Know when to save! Up to 55% off InvestingPro before BLACK FRIDAYCLAIM SALE

Dow Surges 150 Points; US Economy Grows At 2.1% Pace In Q2

Published 30/08/2023, 15:04
© Reuters.  Dow Surges 150 Points; US Economy Grows At 2.1% Pace In Q2
US500
-
DJI
-
IXIC
-

Benzinga - by Lisa Levin, Benzinga Editor.

U.S. stocks traded higher this morning, with the Dow Jones gaining around 150 points on Wednesday.

The Dow traded up 0.44% to 35,006.93 while the NASDAQ rose 0.45% to 14,006.86. The S&P 500, also rose, gaining, 0.40% to 4,515.46.

Check This Out: Ethereum Tops $1,700 Following Economic Data; Stacks Emerges As Top Gainer

Leading and Lagging Sectors

Industrials shares jumped by 0.7% on Wednesday.

In trading on Wednesday, communication services shares rose by just 0.2%.

Top Headline

The U.S. economy expanded at an annualized pace of 2.1% in the second quarter of 2023, versus the preliminary reading of 2.4% and compared to the first quarter's growth of 2.0%.

Equities Trading UP

NanoVibronix, Inc. (NASDAQ: NAOV) shares shot up 126% to $3.32 after the company reported outcomes from a UroShield study conducted at the University of Southampton in the U.K.

Shares of AgileThought, Inc. (NASDAQ: AGIL) got a boost, shooting 66% to $0.2572 after falling 17% on Tuesday.

Digital Brands Group, Inc. (NASDAQ: DBGI) shares were also up, gaining 54% to $13.00. DBGI effected a 1-for-25 reverse stock split on Tuesday.

Equities Trading DOWN

Outlook Therapeutics, Inc. (NASDAQ: OTLK) shares dropped 81% to $0.2625 after the company received an FDA complete response letter regarding ONS-5010, an investigational ophthalmic formulation of bevacizumab under development to treat Wet Age-Related Macular Degeneration (Wet AMD).

Shares of TD Holdings, Inc. (NASDAQ: GLG) were down 25% to $0.22 after dipping 72% on Tuesday.

FibroGen, Inc. (NASDAQ: FGEN) was down, falling 22% to $1.00. FibroGen announced topline data from the Phase 3 LELANTOS-2 trial of pamrevlumab for ambulatory patients with Duchenne muscular dystrophy (DMD) on background systemic corticosteroids.

Also Check This Out: Top 5 Consumer Stocks That May Rocket Higher This Quarter

Commodities

In commodity news, oil traded up 0.7% to $81.76 while gold traded up 0.4% at $1,973.30.

Silver traded up 0.8% to $24.995 on Wednesday while copper rose 0.1% to $3.8420.

Euro zone

European shares were mixed today. The eurozone’s STOXX 600 gained 0.1% London’s FTSE 100 rose 0.4% while Spain’s IBEX 35 Index fell 0.1% The German DAX fell 0.2% French CAC 40 gained 0.1%, while Italy’s FTSE MIB Index gained 0.3%.

The consumer confidence indicator in the Eurozone fell to -16 in August from -15.1 in July, while economic sentiment indicator fell for the fourth straight month to 93.3 in August.

The German consumer price inflation rate fell to 6.1% year-over-year in August from 6.2% in the prior month. Spain’s industry confidence indicator climbed by 2.8 points from the previous month to -6.6 in August. Industrial sales in Italy increased by 0.4% from the prior month in June, while consumer confidence in Italy fell to 106.5 in August from 106.7 in July.

Asia Pacific Markets

Asian markets closed mostly higher on Wednesday, with Japan’s Nikkei 225 gaining 0.33%, China’s Shanghai Composite Index climbing 0.04% and Hong Kong’s Hang Seng Index falling 0.01%. India’s S&P BSE Sensex, meanwhile, rose 0.02%.

The consumer confidence index in Japan fell to 36.2 in August from of 37.1 in July.

Economics

The U.S. economy expanded at an annualized pace of 2.1% in the second quarter of 2023, versus the preliminary reading of 2.4% and compared to the first quarter's growth of 2.0%.

Private businesses in the U.S. added 177,000 workers in August, missing market estimates of a 195,000 rise and compared to a revised 371,000 gain in July.

The US trade deficit in goods widened to $91.2 billion in July versus a revised $88.8 billion in the prior month.

Wholesale inventories in the U.S. fell by 0.1% month-over-month in July.

Corporate profits in the U.S. climbed by 1.6% from the prior quarter to $2.367 trillion in the second quarter.

Now Read This: Kimberly-Clark, Electronic Arts And 2 Other Stocks Insiders Are Selling

COVID-19 Update

The U.S. has the highest number of coronavirus cases and deaths in the world, reporting a total of 107,992,780 cases with around 1,173,420 deaths. India confirmed a total of at least 44,997,030 cases and 531,920 deaths, while France reported over 40,138,560 COVID-19 cases with 167,640 deaths. In total, there were at least 694,499,240 cases of COVID-19 worldwide with more than 6,910,960 deaths.

© 2023 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Read the original article on Benzinga

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.